Dermatology · Mission Viejo, CA
NPI
1730526591
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
23781 Maquina, 2nd Floor Dermatology Department
Mission Viejo, CA, 92691
Phone (888) 988-2800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
2,769 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Nika Cyrus prescribed most often to Medicare patients was Fluorouracil, with 418 prescriptions and refills. In total Nika Cyrus wrote 2,769 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluorouracil Generic | 418 | 420 | 346 | $16K |
| Clobetasol Propionate Generic | 415 | 439 | 211 | $11K |
| Calcipotriene Generic | 272 | 275 | 240 | $40K |
| Ketoconazole Generic | 135 | 141 | 68 | $2,219 |
| Triamcinolone Acetonide Generic | 134 | 186 | 83 | $2,670 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 109 | 122 | 74 | $3,549 |
| Finasteride Generic | 107 | 271 | 35 | $1,402 |
| Tacrolimus Generic | 93 | 99 | 66 | $6,862 |
| Econazole Nitrate Generic | 84 | 85 | 36 | $1,737 |
| Mupirocin Generic | 81 | 81 | 45 | $1,144 |
| Doxycycline Monohydrate Generic | 61 | 70 | 31 | $1,179 |
| Hydrocortisone Generic | 61 | 73 | 40 | $907 |
| Clindamycin Phosphate Generic | 51 | 51 | 29 | $1,102 |
| Dupixent Pen Dupilumab | 44 | 44 | 14 | $186K |
| Ciclopirox Generic | 42 | 45 | 24 | $1,204 |
Brand drugs: 248 claims; generic drugs: 2,521 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Nika Cyrus were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.